Showing results (291-300 of 399) with videos related to

Sort By:
Pageof 40
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2008
Highly parallel identification of essential genes in cancer cellsBiao Luo, Hiu Wing Cheung, Aravind Subramanian, et al.
Oncoimmunology|April 14, 2017
Tumor SQSTM1 (p62) expression and T cells in colorectal cancerKeisuke Kosumi, Yohei Masugi, Juhong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non-Small Cell Lung CancerElena Ivanova, Mari Kuraguchi, Man Xu, et al.
JCO Precision Oncology|December 5, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma RegistrySara A Walton, Justin J Kim, Francesco Paoloni, et al.
Science Translational Medicine|April 13, 2018
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasmsOfir Wolach, Rob S Sellar, Kimberly Martinod, et al.
American Journal of Hematology|October 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center StudyOren Pasvolsky, Shai Shimony, Rima M Saliba, et al.
Science Translational Medicine|November 3, 2017
A precision therapy against cancers driven by KIT/PDGFRA mutationsErica K Evans, Alexandra K Gardino, Joseph L Kim, et al.
Blood|May 21, 2021
The clinical and functional effects of TERT variants in myelodysplastic syndromeChristopher R Reilly, Mikko Myllymäki, Robert Redd, et al.
American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.
Cancer Discovery|April 15, 2017
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung CancerDennis O Adeegbe, Yan Liu, Patrick H Lizotte, et al.
Pageof 40